How we see the future of patient access
Transmineo is building a data-driven infrastructure to accelerate patient access to innovative and personalized treatments. Too many breakthrough therapies are delayed because decision-makers lack robust evidence at the right time. Without better solutions, patients wait — and innovation fails to achieve sustainable commercial success.
As the developer of the MyOwnData platform, Transmineo enables the structured collection of Real World Data (RWD) directly from patients and clinical practice to generate regulatory-grade Real World Evidence (RWE) to support Regulatory Decisions, Health Technology Assessments (HTAs), Reimbursement, and Value-based Agreements across the full Lifecycle of Innovative Treatments.
Patients’ willingness to contribute to studies is pivotal for high quality RWE. That’s why MyOwnData combines secure data collection with a patient-friendly user experience. Developed in co-creation with patients, the platform offers an intuitive dashboard, real-time health insights, and full control over data access. Gamification and reward mechanisms recognize patients’ contributions, while giving them direct benefit from access to their own data.
Well-positioned within GDPR, the Data Governance Act, the Data Act, and the European Health Data Space, Transmineo delivers a compliant, secure, and scalable platform that turns RWD into high-quality RWE to help make patient access to innovative therapies faster, more secure, and commercially viable.
Transmineo’s services will be complimentary to Keen Access Insights’ offers.
Transmineo is not “another health data platform”
It is:
– Engineering trust
– Architecting compliant data ecosystems
– Designing patient-controlled RWD pipelines
– Building future-proof RWE infrastructure
Contact Us
If you want to know more about Keen Access Insights’ consulting services or about Transmineo’s developments